Evidence map›Paper›PMID 41505127›Full record

ArticleJAMA network open2026

Maternal Vaccine Receipt and Infant Hospital and Emergency Visits for Influenza and Pertussis.

Gabriella Morabito, Giovanni Corrao, Carlo Giaquinto, Anna Cantarutti, Costanza Di Chiara

Abstract read
In one paragraph

Article in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gabriella MorabitoNational Centre for Healthcare Research and Pharmacoepidemiology, at the University of Milano-Bicocca Milan, Italy.
Giovanni CorraoUniversity of Milano-Bicocca (Emeritus Professor), Milan, Italy.
Carlo GiaquintoDepartment for Women's and Children's Health, University of Padua, Padua, Italy.
Anna CantaruttiNational Centre for Healthcare Research and Pharmacoepidemiology, at the University of Milano-Bicocca Milan, Italy.
Costanza Di ChiaraDepartment for Women's and Children's Health, University of Padua, Padua, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Influenza and tetanus-diphtheria-acellular pertussis (Tdap) vaccinations during pregnancy offer protection to infants from infections. However, evidence about their effectiveness against hospitalization and emergency department (ED) visits associated with influenza and pertussis remains limited. Objective: This study aimed to evaluate the association of maternal influenza and Tdap vaccinations with influenza- and pertussis-related hospitalizations and ED visits in infants younger than 6 months. Design, Setting, and Participants: This population-based cohort study used the health care utilization databases from the Lombardy region of Italy. Pregnant individuals who received the influenza and Tdap vaccine among all live-birth pregnancies in 2018 to 2022 were included. Each vaccinated mother was matched with a nonvaccinated counterpart based on month and year of delivery, gestational age at birth, and pregnancy multiplicity. Analyses were performed from April 2024 to February 2025. Exposures: Exposures of interest were influenza and Tdap vaccinations during pregnancy. Main Outcomes and Measures: The primary outcomes were infant hospitalizations or ED visits due to influenza and pertussis. Cox regression models were fitted to estimate the hazard ratio (HR) of each outcome associated with the corresponding maternal vaccine. Vaccine effectiveness (VE) was calculated as VE = (1 - HR) × 100%. Results: This study included 53 448 pregnant individuals who received the Tdap vaccine and 5347 who received influenza vaccine. The maternal vaccination coverage (ie, proportion of vaccinated pregnant individuals among those eligible) was 5359 (6.4%) for influenza and 70 119 (41.0%) for Tdap, respectively. Infants born to mothers who received the influenza and Tdap vaccine had a lower risk of hospitalization or ED visit for influenza (VE, 69.7%; 95% CI, 8.7%-90.0%) and pertussis (VE, 88.6%; 95% CI, 11.5%-98.5%), respectively. Conclusions and Relevance: This study found that maternal influenza and Tdap vaccinations were associated with reduced influenza- and pertussis-related hospitalization or ED visits in infants younger than 6 months. Given the low vaccination coverage, it is crucial to implement maternal vaccination campaigns to enhance infant health outcomes.

Indexed as

Diphtheria-Tetanus-acellular Pertussis VaccinesEmergency Service, HospitalHospitalizationInfluenza, HumanInfluenza VaccinesVaccinationWhooping CoughAdultCohort StudiesEmergency Room VisitsFemaleHumansInfantInfant, NewbornItalyMaleDiphtheria-Tetanus-acellular Pertussis VaccinesInfluenza Vaccines

Identifiers

PMID41505127
PMCPMC12784226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.